316 related articles for article (PubMed ID: 8922768)
21. Dose-response relationships for edrophonium antagonism of mivacurium-induced neuromuscular block during N2O-enflurane-alfentanil anaesthesia.
Marcotte J; Drolet P; Perreault L; Girard M
Can J Anaesth; 1995 Oct; 42(10):879-83. PubMed ID: 8706197
[TBL] [Abstract][Full Text] [Related]
22. Edrophonium requirements for reversal of deep neuromuscular block following infusion of mivacurium.
Miller DR; Bryson G; Martineau RJ; Kitts JB; Curran M; Bragg P; Watson JB; Hull K; Lindsay P
Can J Anaesth; 1995 Nov; 42(11):996-1002. PubMed ID: 8590511
[TBL] [Abstract][Full Text] [Related]
23. The clinical neuromuscular pharmacology of mivacurium chloride (BW B1090U). A short-acting nondepolarizing ester neuromuscular blocking drug.
Savarese JJ; Ali HH; Basta SJ; Embree PB; Scott RP; Sunder N; Weakly JN; Wastila WB; el-Sayad HA
Anesthesiology; 1988 May; 68(5):723-32. PubMed ID: 2967039
[TBL] [Abstract][Full Text] [Related]
24. [Effects of different doses of edrophonium antagonism of mivacurium-induced neuromuscular block in the presence of nitrous oxide, propofol, and alfentanil anesthesia].
Ripart J; Drolet P; Perreault L; Girard M
Can J Anaesth; 1996 Apr; 43(4):368-72. PubMed ID: 8697552
[TBL] [Abstract][Full Text] [Related]
25. Effect of neostigmine at different levels of mivacurium-induced neuromuscular blockade.
Trévien V; Lienhart A; Just B; Chandon M; Baras E; Camatte S
Acta Anaesthesiol Scand Suppl; 1995; 106():66-9. PubMed ID: 8533550
[TBL] [Abstract][Full Text] [Related]
26. Spontaneous versus edrophonium-induced recovery from paralysis with mivacurium.
Brandom BW; Taiwo OO; Woelfel SK; Schön H; Gronert BJ; Cook DR
Anesth Analg; 1996 May; 82(5):999-1002. PubMed ID: 8610913
[TBL] [Abstract][Full Text] [Related]
27. Mivacurium-induced neuromuscular blockade in patients with atypical plasma cholinesterase.
Ostergaard D; Jensen FS; Jensen E; Skovgaard LT; Viby-Mogensen J
Acta Anaesthesiol Scand; 1993 Apr; 37(3):314-8. PubMed ID: 8390770
[TBL] [Abstract][Full Text] [Related]
28. Reversal of mivacurium-induced neuromuscular blockade with a cholinesterase inhibitor: A systematic review.
Brinch JHW; Söderström CM; Gätke MR; Madsen MV
Acta Anaesthesiol Scand; 2019 May; 63(5):564-575. PubMed ID: 30548256
[TBL] [Abstract][Full Text] [Related]
29. Mivacurium chloride: a study to evaluate its use during propofol-nitrous oxide anaesthesia.
Wrigley SR; Jones RM; Harrop-Griffiths AW; Platt MW
Anaesthesia; 1992 Aug; 47(8):653-7. PubMed ID: 1387765
[TBL] [Abstract][Full Text] [Related]
30. To reverse or not to reverse: an evaluation of reversal of mivacurium chloride in women undergoing outpatient gynecological procedures.
Jahr JS; Keller T; Williams MD; Liukkonen JR; Anwar M; Paxtor CG; Greene M; Gitlin MC
Am J Ther; 1997; 4(9-10):315-22. PubMed ID: 10423625
[TBL] [Abstract][Full Text] [Related]
31. Edrophonium effectively antagonizes neuromuscular block at the laryngeal adductors induced by rapacuronium, rocuronium and cisatracurium, but not mivacurium.
Suzuki T; Lien CA; Belmont MR; Tjan J; Savarese JJ
Can J Anaesth; 2003 Nov; 50(9):879-85. PubMed ID: 14617582
[TBL] [Abstract][Full Text] [Related]
32. Spontaneous recovery or evoked reversal of neuromuscular block.
Mirakhur RK
Acta Anaesthesiol Scand Suppl; 1995; 106():62-5. PubMed ID: 8533549
[TBL] [Abstract][Full Text] [Related]
33. Optimum time for neostigmine reversal of atracurium-induced neuromuscular blockade.
Kirkegaard-Nielsen H; Helbo-Hansen HS; Lindholm P; Severinsen IK; Pedersen HS; Jensen EW
Can J Anaesth; 1996 Sep; 43(9):932-8. PubMed ID: 8874911
[TBL] [Abstract][Full Text] [Related]
34. Edrophonium increases mivacurium concentrations during constant mivacurium infusion, and large doses minimally antagonize paralysis.
Hart PS; Wright PM; Brown R; Lau M; Sharma ML; Miller RD; Gruenke L; Fisher DM
Anesthesiology; 1995 Apr; 82(4):912-8. PubMed ID: 7717563
[TBL] [Abstract][Full Text] [Related]
35. Effect of metoclopramide on mivacurium-induced neuromuscular block.
Motamed C; Kirov K; Combes X; Dhonneur G; Duvaldestin P
Acta Anaesthesiol Scand; 2002 Feb; 46(2):214-6. PubMed ID: 11942874
[TBL] [Abstract][Full Text] [Related]
36. Influence of plasma cholinesterase activity on recovery from mivacurium-induced neuromuscular blockade in phenotypically normal patients.
Ostergaard D; Jensen FS; Jensen E; Skovgaard LT; Viby-Mogensen J
Acta Anaesthesiol Scand; 1992 Oct; 36(7):702-6. PubMed ID: 1441874
[TBL] [Abstract][Full Text] [Related]
37. Dose-response relationships for edrophonium and neostigmine antagonism of atracurium and cisatracurium-induced neuromuscular block.
Naguib M; Riad W
Can J Anaesth; 2000 Nov; 47(11):1074-81. PubMed ID: 11097536
[TBL] [Abstract][Full Text] [Related]
38. Neuromuscular and clinical effects of mivacurium chloride in healthy adult patients during nitrous oxide-enflurane anaesthesia.
Goldhill DR; Whitehead JP; Emmott RS; Griffith AP; Bracey BJ; Flynn PJ
Br J Anaesth; 1991 Sep; 67(3):289-95. PubMed ID: 1832920
[TBL] [Abstract][Full Text] [Related]
39. Comparison of the effects of neostigmine and edrophonium on the duration of action of suxamethonium.
McCoy EP; Mirakhur RK
Acta Anaesthesiol Scand; 1995 Aug; 39(6):744-7. PubMed ID: 7484027
[TBL] [Abstract][Full Text] [Related]
40. Antagonism of mivacurium block with edrophonium from various degrees of spontaneous recovery.
Connolly FM; Mirakhur RK; Loan PB; McCoy EP; Symington M; Kumar N
Br J Anaesth; 1995 Feb; 74(2):229-30. PubMed ID: 7696074
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
